Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Item
http://www.wikidata.org/entity/Q34341331
Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerDifferentiated Thyroid Cancer-Treatment: State of the Art.I-131 for Remnant Ablation in Differentiated Thyroid Cancer After Thyroidectomy: A Meta-Analysis of Randomized Controlled Evidence.Targeted radionuclide therapy.Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer.Implication of different clinical and pathological variables in patients with differentiated thyroid cancer on successful ablation for 3700 MBq (131)I: a single Egyptian institutional experience over 14 years.Comparison of effective I-131 half-life between thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone for thyroid cancer: a retrospective study.Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity.A comparison of low versus high radioiodine administered activity in patients with low-risk differentiated thyroid cancer.Case of radioactive iodine exposure during pregnancy.Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131 I-NaI treatments of differentiated thyroid cancer.
P2860

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

Item
http://www.wikidata.org/entity/Q34341331
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@ast
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@en
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@nl
type
label
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@ast
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@en
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@nl
prefLabel
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@ast
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@en
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Radioiodine thyroid remnant ab ...... atment with 30, 60 and 100 mCi
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P932